Compounds > carbapenems
Page last updated: 2024-09-04

carbapenems and sitafloxacin

carbapenems has been researched along with sitafloxacin in 4 studies

Compound Research Comparison

Studies
(carbapenems)		Trials
(carbapenems)		Recent Studies (post-2010)
(carbapenems)		Studies
(sitafloxacin)		Trials
(sitafloxacin)		Recent Studies (post-2010) (sitafloxacin)
7,3551475,2771852285

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Kaneko, T; Kato, N; Liu, CX; Sakata, T; Watanabe, K1
Thamlikitkul, V; Tiengrim, S1
Chang, SC; Chuang, YC; Huang, YS; Sheng, WH; Wang, JT1
Guo, S; Li, X; Li, Y; Shao, J; Tian, M; Tong, H; Wei, M; Xu, B; Yan, B1

Other Studies

4 other study(ies) available for carbapenems and sitafloxacin

ArticleYear
Impact of a new quinolone, DU-6859a, and two oral carbapenems, CS-834 and L-084, on the rat and mouse caecal microflora.
    The Journal of antimicrobial chemotherapy, 2000, Volume: 46, Issue:5

    Topics: Animals; Anti-Infective Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Carbapenems; Cecum; Fluoroquinolones; Male; Mice; Prodrugs; Rats; Rats, Wistar

2000
In vitro activity of sitafloxacin against carbapenem-resistant Acinetobacter baumannii.
    International journal of antimicrobial agents, 2013, Volume: 42, Issue:3

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Asia, Southeastern; beta-Lactam Resistance; Carbapenems; Cross Infection; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Pneumonia, Bacterial

2013
Comparative in vitro activity of sitafloxacin against bacteremic isolates of carbapenem resistant Acinetobacter baumannii complex.
    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2015, Volume: 48, Issue:5

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Carbapenems; DNA, Bacterial; DNA, Intergenic; DNA, Ribosomal; Fluoroquinolones; Humans; Microbial Sensitivity Tests; RNA, Ribosomal, 16S; RNA, Ribosomal, 23S; Sequence Analysis, DNA

2015
Sitafloxacin pharmacokinetics/pharmacodynamics against multidrug-resistant bacteria in a dynamic urinary tract infection in vitro model.
    The Journal of antimicrobial chemotherapy, 2022, 12-23, Volume: 78, Issue:1

    Topics: Anti-Bacterial Agents; Bacteria; Carbapenems; Escherichia coli; Fluoroquinolones; Humans; Levofloxacin; Microbial Sensitivity Tests; Urinary Tract Infections; Vancomycin

2022